Experience the interactive Multichannel News Release here:
https://www.multivu.com/players/English/8950551-neurocrine-biosciences-expands-monumental-moments-program-with-jorge-rodriguez-gerada/
Inspired by the hundreds of stories shared on MonumentalMoments.com over the past year, Monumental Moments - The Hug was unveiled on
The Monumental Moments community platform and charitable initiative was created to offer hope, support, inspiration and a way for the mental health community and all those facing challenges during the pandemic to connect and share how they're prioritizing their mental health. The Monumental Moments community is now encouraging people to share any lessons learned since the start of the pandemic, what they are grateful for and how they continue to care for their mental health.
"I am honored to work with
To usher in this time of reflection, Rodriguez-Gerada's sculpture of a hug, developed in collaboration with international art and design foundry UAP, represents the importance of connection and supporting each other and how much many of us missed hugging loved ones during these trying times. Research demonstrates that hugging can help minimize negative emotions and support a more positive state of being.1 The sculpture depicts two adults and a child in an embrace, and the green ribbon woven throughout represents the importance of continued mental health awareness and support, while highlighting the significance of this year's Mental Illness Awareness Week and World Mental Health Day.
"Last year in support of the launch of Monumental Moments, we debuted an original score to bring to life the emotional impact this time has had on many," said
One in five adults live with a mental health condition,2 and research from the Kaiser Family Foundation (KFF) Health Tracking Poll, a KFF survey tool, found nearly half (47%) of adults continue to report negative mental health impacts as a result of the pandemic.3 People living with mental health conditions may also be impacted by tardive dyskinesia (TD), a movement disorder associated with taking medication to treat bipolar disorder, depression or schizophrenia.4-6 These movements are characterized by uncontrollable, abnormal, and repetitive movements of the face, torso, and/or other body parts, which can impact those living with TD socially, emotionally, and physically.4-8
Public posts on social media using the hashtag #MonumentalMoments will help support people living with mental health conditions, including those living with TD, and the challenges that they may experience. On behalf of posts shared,
"At Neurocrine Biosciences, we remain committed to supporting people living with mental health conditions and associated challenges like tardive dyskinesia," said
For more information including mental health resources, visit MonumentalMoments.com or Facebook.com/MonumentalMomentsPage and join the conversation online by sharing #MonumentalMoments.
About Tardive Dyskinesia (TD)
Tardive dyskinesia (TD) is an involuntary movement disorder characterized by uncontrollable, abnormal and repetitive movements of the torso, extremities and/or face, which can include hand or foot movements, rocking of the torso, lip smacking, grimacing, tongue protrusion, facial movements or blinking, as well as puckering and pursing of the lips. The condition is associated with taking certain mental health medicines such as antipsychotics, which are commonly prescribed to bipolar disorder, depression and schizophrenia. In patients with TD, these treatments are thought to result in irregular dopamine signaling in a region of the brain that controls movement. The symptoms of TD can be severe and are often persistent and irreversible. TD is estimated to affect approximately 600,000 people in the
About Neurocrine Biosciences
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and delivering life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis*, uterine fibroids* and clinical programs in multiple therapeutic areas. For nearly three decades, Neurocrine Biosciences has specialized in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems. For more information, visit neurocrine.com, and follow the company on LinkedIn. (*in collaboration with AbbVie)
About
About Me2/Orchestra
Me2/Orchestra is the world's only known classical music organization created specifically for individuals living with mental illness and the people who support them. Founded in 2011 by
1 Robinson KJ, Hoplock LB, Cameron JJ. When in doubt, reach out: touch is a covert but effective mode of soliciting and providing social support. Soc Psychol Personal Sci. 2015;6(7):831-839. doi:10.1177/1948550615584197
2 National Alliance on Mental Illness. Mental health by the numbers. Accessed
3 Kearney A, Hamel L, Brodie M. KFF Health Tracking Poll – mental health impact of the COVID-19 pandemic: an update.
4 Task Force on Tardive Dyskinesia. Tardive Dyskinesia: A
5 Cloud LJ, Zutshi D,
6
7 Guy W. ECDEU Assessment Manual for Psychopharmacology.
8
SOURCE
Tony Jewell (Media), 858-617-7578, media@neurocrine.com; Todd Tushla (Investors), 858-617-7143, ir@neurocrine.com